The move marks an advancement in reducing plastic waste and assisting global brands in achieving their sustainability ...
The FDA’s latest draft guidance on accelerated approval for new drugs, “Expedited Program for Serious Conditions—Accelerated ...
Proposals to eliminate the self-affirmed GRAS pathway have sent shockwaves through the food industry. But what do they mean ...
The U.S. health secretary has vowed to close an FDA loophole that has allowed food companies to self-police the safety of new ...
RedHill plans to submit UK MAA1 for Talicia for H. pylori infection, using MHRA's2 new fast-track approval process, referencing FDA approval, with potential UK approval ...
Mehmet Oz, President Trump’s pick to lead the CMS, said Medicare beneficiaries should have quicker access to new medical ...
Explore RFK Jr's push for GRAS reform and its impact on food safety. Experts David Acheson and Dr Darin Detwiler discuss ...
FILSPARI REMS: Due to the risk of hepatotoxicity and embryo-fetal toxicity, FILSPARI is available only through a restricted program called the FILSPARI REMS. Prescribers, patients, and pharmacies must ...
The FDA has approved an expanded indication of Soliris, an IV-administered monoclonal antibody for patients aged 6 years and ...
Eli Lilly, Adaptimmune, Aurion Biotech, and ImmunityBio had breakthrough medicines and therapies debut in the past year.
It’s time to revamp the FDA’s “generally recognized as safe,” or GRAS, program that allows companies to add untested ...